Board of Directors

Home About the Pancreatic Cancer Action Network Our Leadership Board of Directors

Jeanne Weaver Ruesch
Chair
Chevy Chase, MD

Hilarie Koplow-McAdams
Vice Chair
San Francisco, CA

Peter Cashion
Washington, DC

Julie M. Fleshman, JD, MBA
President and CEO
Los Angeles

Scott A. Griswold, CPA
Los Angeles, CA

Barbara J. Kenner, PhD
New York, NY

Michael A.G. Korengold
Chair, Audit and Investment Committee
New York, NY

Peter Kovler
Washington, DC

Jason Kuhn
Tampa, FL

Laurie MacCaskill
Immediate Past Chair
Los Angeles, CA

Terrence Meck
Provincetown, Mass.

Stuart Rickerson
Rancho Santa Fe, CA

Craig A. Rogerson
Philadelphia, PA

Karen Young, CPA
New Jersey


Jeanne Weaver Ruesch

Chair

Chevy Chase, MD

Jeanne Weaver Ruesch is Chair of the Ruesch Family Foundation, a charitable entity in the Washington region, founded in 2004 by she and her late husband, Otto J. Ruesch. Prior to the foundation’s founding, Ruesch served as the Executive Vice President and Chief Operating Officer of Ruesch International, an international financial services company with nine offices in the United States and Europe providing global payment solutions for corporations worldwide.

Ruesch was previously affiliated with the Westinghouse Electric Corporation in the corporate business planning and consulting sector. As a former federal employee, she helped craft provisions of the Youth Development and Delinquency Prevention Act and the Runaway Youth Act while at the U. S. Department of Health, Education and Welfare. She ended her tenure with the Department acting in the capacity of Commissioner. At the U.S. Department of Labor, Ruesch worked with the Neighborhood Youth Corps Program. As an associate of the National Urban Coalition, she developed and managed programs focusing on the application of private sector methodologies to urban development problems.

Ruesch is President of the National Symphony Orchestra at the Kennedy Center, member of the Kennedy Center International Committee, and the Executive Committee of Georgetown Medical Center Doctors Speak Out. She is affiliated with two corporate boards, serving as Chair of the Board of Directors of AUI Imports and a member of the Bialek Environments Advisory Committee. She has previously served as a Trustee of Georgetown University, and chair of the Audit Committee, Chair of the Corcoran Museum + College of Art Board of Trustees, Vice Chair of Gonzaga College High School’s Board of Directors, Trustee of the Washington Performing Arts Society, Chair of the Advancement Committee of Catholic Charities, Chair of the Advancement Committee of the Washington Jesuit Academy, and member of the finance committee of Holy Trinity Catholic Church. She is also a member of The Committee of 200, a world-wide organization for entrepreneurial business women. With her late husband, she co-chaired the 2004 Catholic Charities Foundation’s 75th Anniversary Diamond Jubilee Gala and co-chaired the Kennedy Center’s 2001 Spring Gala. Both she and her husband were named Outstanding Volunteer Fundraisers in 1999 by the DC Chapter of Professional Fundraisers, were recipients of the 2001 SOAR! Elizabeth Ann Seton Award, the 2002 So Others Might Eat (SOME) Humanitarian Award, the 2005 Catholic Charities Voice of Hope Award, and the 2008 Providence Hospital Advocate Award.

Ruesch has two sons, Matthew and Christoph, and lives in Chevy Chase, Maryland.

back to top


Hilarie Koplow-McAdams

Hilarie Koplow-McAdams

Vice Chair

San Francisco, CA

Hilarie Koplow-McAdams joined the technology team of New Enterprise Associates (NEA) as a Venture Partner in 2017, where she focuses on enterprise software and services. She also serves as an independent board director across several public companies.

An enterprise software veteran, Koplow-McAdams spent the last three decades at growth-stage technology companies in operations and board roles. Most recently, she was President at New Relic, responsible for the company’s growth strategies as well as leading global sales, marketing, customer success, support and business development. Prior to New Relic, Koplow-McAdams was at Salesforce, who named her President to lead the company’s worldwide sales teams, focused on growing the business globally. Koplow-McAdams joined Salesforce from Intuit, where she was Vice President of Direct Sales for small business and a member of the executive committee.

Koplow-McAdams started her career at Oracle Corporation. She held a variety of roles over the course of 18 years at the company, including Senior Vice President of Oracle Direct, where she drove the company’s rapid growth in the technology and applications markets.

Koplow-McAdams currently serves as a member of the board of directors for Tableau and Zendesk as well as Vice Chair of the Pancreatic Cancer Action Network. She is also a member on the advisory council of the University of Chicago’s Harris School of Public Policy. She previously served on the board of directors for Informatica, now a private company.

Koplow-McAdams has a master’s degree in Public Policy from the University of Chicago and a bachelor’s degree from Mills College. She lives in the San Francisco Bay Area with her husband Steve and their two daughters.

back to top


Peter Cashion

Washington, D.C.

Peter Cashion is a Chief Investment Officer at the International Finance Corporation (IFC), a member of the World Bank Group, in Washington, D.C. Cashion and his two teenage sons lost wife and mother Andra Tamburro to pancreatic cancer in 2013. 

Cashion began his career at IFC in 1995. He has held a variety of senior positions in the Washington, D.C. office and in the field, including postings in Cote d’Ivoire, Senegal, and Turkey. Since relocating from Istanbul to D.C. in 2012, he’s been active in promoting women’s entrepreneurship and overseeing the equity investment business in financial institutions.

Cashion was IFC’s representative on the Steering Committee of the IFC-Goldman Sachs Foundation Women Entrepreneurs Opportunity Facility, a $600 million financing facility for women entrepreneurs in emerging markets. Currently, he is the equity head of the Financial Institutions Group at IFC. Cashion has a regional focus on sub-Saharan Africa and Latin America and oversees an equity portfolio of $2 billion.

Previously, he served in the IFC Treasury for eight years, during which time he was the IFC board member nominee to Titularizadora Colombian (Colombia), the largest mortgage securitization company in Colombia. 

Since his wife’s passing, Cashion and his boys have been committed, passionate fundraisers for the Pancreatic Cancer Action Network through PurpleStride Washington, D.C. They raised over $180,000 from 2013-2017. 

back to top


Julie Fleshman, JD, MBA

President and Chief Executive Officer

Los Angeles, CA

The Pancreatic Cancer Action Network is a nonprofit, 501(c)(3) nationwide network of people dedicated to fighting the world’s toughest cancer. Founded by a group of pancreatic cancer survivors and caregivers in 1999, the organization relentlessly pursues its mission by implementing an aggressive and comprehensive strategy of research, patient support, advocacy and awareness. The Pancreatic Cancer Action Network is headquartered in Manhattan Beach, Calif., and also staffs a Washington, D.C and New York City office.

Julie Fleshman became the organization’s first full-time staff person and its first Executive Director in April 2000. Having lost her father to pancreatic cancer in 1999, she has made it her passion and commitment to change the course of the disease. In July 2004, the Board of Directors appointed Fleshman President and CEO. Under her leadership, the Pancreatic Cancer Action Network has grown from a staff of one with revenues of $228,000 to a staff of over 140 with a budget of more than $38 million.

Today, Fleshman is a sought-after speaker with considerable experience addressing diverse stakeholder groups, including Congress, industry, patients, scientists, donors and volunteers. She has also been interviewed by national media such as The New York Times, CNN, Headline News and ABC News as well as local press throughout the country.

Fleshman has spearheaded the charge to ensure the Pancreatic Cancer Action Network achieves its goal to double pancreatic cancer survival by 2020. Her leadership has driven consistent excellence and innovation throughout the programs and services of the organization, including introducing precision medicine service Know Your Tumor® and Precision PromiseSM, the first large-scale adaptive clinical trial for pancreatic cancer. At the same time, she has steadily increased revenue growth and the organization’s impact. Under her direction, the organization has greatly expanded and attracted leading researchers from prestigious institutions around the country to study pancreatic cancer.

During Fleshman’s tenure, advocacy and grassroots efforts have expanded to over 60 affiliates nationwide and yielded a $100 million increase in federal funding for pancreatic cancer research. The organization has awarded 159 pancreatic cancer research grants totaling over $40 million to researchers at institutions around the country. And more than 165,000 pancreatic cancer patients and their families nationwide have been served by the organization’s patient services program.

Fleshman holds her JD and MBA degrees from Santa Clara University and a BA from the University of California, Santa Barbara, where she graduated Magna Cum Laude. She also studied abroad at Oxford University and in Tokyo, Japan. Fleshman has been honored for her leadership and dedication in the fight against pancreatic cancer by many organizations. She serves on the boards of several cancer care and research committees and organizations, recently completing her term as a patient advocate on the National Cancer Institute’s Pancreas Task Force, and she has been published in multiple research journals. Most recently, she was asked to join the FasterCures Patients Count Leadership Council and to serve on the NCI Council of Research Advocates to provide advice to the NCI Director with respect to promoting research outcomes that are in the best interest of cancer patients. In addition, Fleshman is the Chair of the World Pancreatic Cancer Coalition, a coalition of more than 60 pancreatic cancer organizations representing 27 countries around the globe.

back to top


Michael A.G. Korengold

Chair, Audit and Investment Committee

New York, NY

Michael A.G. Korengold is a finance executive based in New York City. His commitment to fighting pancreatic cancer is rooted in the loss of his mother, Melanie Gainsley, to the disease in 1995.

Currently, Korengold is President and Chief Executive Officer of Enhanced Capital, a national asset management firm focused on lending to businesses throughout the United States. He serves on the firm’s Investment Committees and Board of Directors. Prior to becoming president in 2003, Korengold was the company’s Sr. Vice President and General Counsel. Earlier, he practiced law in Minneapolis and New Orleans, with an emphasis on corporate finance.

Korengold has lectured extensively on capital formation programs and has testified before numerous state legislatures and other governmental institutions on related issues. He has also served on the boards of numerous civic, community and charitable organizations and is currently a co-chairman of the Young Presidents’ Organization, Gotham Chapter.

After receiving his bachelor’s degree from Vassar College in 1986, Korengold graduated magna cum laude from the University of Minnesota Law School in 1993. There, he was a member of the Order of the Coif honor society and served as an editor of the Law Review.

Korengold lives in Bronxville, New York, with his wife, Jonalie, and his two children, Ben and Gainsley, who is named after his mother.

back to top


Scott A. Griswold, CPA

Los Angeles, CA

Scott A. Griswold, CPA, spent the bulk of his professional life working for David Murdock, owner of Dole Food Company and self-made billionaire. Throughout his career, Griswold provided investment and financial analysis, along with operational oversight.

While Griswold retired as executive vice president (EVP) of corporate development at Dole in 2013, he continued to work at Castle and Cooke Inc., a private holding company for various enterprises owned by Murdock as their EVP of Operations. He made his retirement official in 2014. Currently he spends his free time pursuing leisure activities like golf, and by donating his time and skills to various not-for-profit organizations.

Griswold graduated from Iowa’s Luther College with a bachelor of arts degree in accounting. After graduating, he moved to Los Angeles, where he began his professional career within the audit division of Arthur Anderson & Co. He left Arthur Anderson & Co. a decade later as a senior audit manager.

Griswold also serves as a member of the Buck Institute for Research on Aging Impact Circle, an organization responsible for selecting and providing seed money for scientists to do initial testing of their hypothesis. The first two projects received initial funding from the National Institutes of Health (NIH). Formerly, Griswold served as a member of the Board of Directors of the Hollywood YMCA and as a member of the Los Angeles World Affairs Council.

Griswold became passionate about pancreatic cancer awareness, advocacy, fundraising and research after he lost a dear family friend to the disease in 2015.

For the past four decades, Griswold has lived in Manhattan Beach, CA. His late wife Pamela died of lung cancer in 2016. Griswold has two adult children, James who lives in Manhattan Beach and Tracey who lives in Gilbert, AZ.

back to top


Barbara J. Kenner, PhD

New York, NY

Barbara Kenner, PhD, established the Kenner Family Research Fund (KFRF) in 2013 in memory of her husband, Peter, who died in 2010 just two months after he was diagnosed with neuroendocrine pancreatic cancer. The mission of KFRF is to further advance early detection of pancreatic cancer by actively promoting inter-professional strategic collaboration among researchers, government, industry and patient advocacy groups. The Kenner Family Research Fund provides a platform to share the varied expertise and diverse perspectives that challenge current thinking. Published articles resulting from these collaborative forums provide a broader reach of information to the pancreatic cancer community.

Kenner serves as an advocate to the National Cancer Institute’s Alliance of Pancreatic Cancer Detection Consortium (PCDC) and the Stand Up To Cancer-Lustgarten Foundation Pancreatic Cancer Interception Dream Team. She is a founding member of the World Pancreatic Cancer Coalition and is also on the board of the American Pancreatic Foundation and the Board of Associate Editors for Pancreas Journal.

Kenner is a founding partner of Neuropsychological Assessment and Consultation Services LLP, which provides neuropsychological assessment services for children, adolescents and adults.

She earned her PhD from New York University Steinhardt School and completed pre- and postdoctoral fellowships at Mount Sinai Medical Center in New York City.

A past member of the NYU Steinhardt Dean’s Council, she has received the school’s Distinguished Alumna Achievement Award.

Kenner lives in New York City, where she serves on various boards, including the Weizmann Institute’s Women in Philanthropy and Bard College Music Festival. Kenner’s family, including Nick and Ashley Kenner, Kate and Sam Archibald, and her four grandchildren, also live in New York City.

back to top


Peter Kovler

Washington, DC

Peter Kovler serves as the Director of the Marjorie Kovler Philanthropic Fund and as Chairman of the Board of the Blum-Kovler Foundation. He also serves as the Chairman of the Board of the Center for National Policy and is the founder of Chicago’s Kovler Center for Survivors of Torture. With an impressive background in government affairs, Kovler previously worked as an award-winning documentary producer, as well as an acclaimed editor, speech writer and reporter. In 1970, Kovler lost his mother to pancreatic cancer; he now serves as a committed advocate to advancing research into the disease. He lives in Washington, D.C. with his wife, Judy.

back to top


Jason Kuhn

Tampa, FL

Jason Kuhn, a native of Allentown, Penn., graduated from Washington University in St. Louis with a degree in Business Administration. He earned his law degree at Cardozo Law School in New York City and his LL.M. in tax law at New York University School of Law. Subsequently, he worked as a tax consultant for KPMG in its Manhattan headquarters.

Kuhn entered the automobile business in 1996, and he currently serves as Chairman and CEO of Kuhn Automotive Group, based in Tampa, Fla. His company employs approximately 300 people and also has locations in Tampa, Atlanta and soon in Columbus, Ohio.

He served as Chairman of the National Dealer Council for Volkswagen for three years and was one of the youngest members ever elected to the Board of Directions for the Florida Automobile Dealers Association.

Kuhn first joined the Board of Directors of the Pancreatic Cancer Action Network in 2003, shortly after his father was diagnosed with pancreatic cancer. He served for nine years and spent three-and-a-half of those years as Chair before taking a short hiatus. He is delighted to rejoin the Board for a second term.

In a private capacity, Kuhn funds pancreatic cancer research at Moffitt Cancer Center in Tampa, the University of South Florida and Mayo Clinic in Rochester, Minn. He has also been involved with the Tampa Art Museum, St. Joseph’s Hospital, Tampa Jewish Federation and the Berkeley Preparatory School.
He lives in Tampa with his wife, Courtney, and their four children.

back to top


Laurie MacCaskill

Immediate Past Chair

Los Angeles, CA

Los Angeles-resident, Laurie MacCaskill is a professional speaker and 11+ year pancreatic cancer survivor. Known for her inspiring story, Treatment on the Trail, MacCaskill takes audiences on her life-changing journey through her experience with one of the deadliest cancers that exist. 
 
As an effortless volunteer for multiple non-profit organizations, MacCaskill has served as a board member for the Pancreatic Cancer Action Network from 2009 to 2017 and is the immediate past chair of the board. She has served on the Board of Directors and as Chairman of the Board for the National Committee for the Performing Arts with the Kennedy Center in Washington, D.C., and was one of the founding board members of the Aspen Center for Integral Health in Colorado.
 
MacCaskill has worked as a professional coach with a focus on honing communication skills of executives at Fortune 500 companies.
 
MacCaskill’s story provides a framework for others to redefine how they look at their own lives. Audiences leave feeling courageous, reinvigorated and ready to be their own advocate through individual adversities. Find out more about MacCaskill at www.lauriemaccaskill.com

back to top


Terrence Meck

Provincetown, Mass.

Terrence Meck is co-founder and president of The Palette Fund, a private foundation dedicated to advancing social change in communities that are under-resourced and facing significant challenges. The Palette Fund honors the legacy of his late partner Rand Skolnick who lost his battle to pancreatic cancer in 2008. Since its inception, the foundation has granted more than $5 million to over 125 organizations throughout the United States and abroad.

Meck also serves as president of Intrinsic Capital, a small investment firm dedicated to providing seed-stage funding to socially progressive startups. He recently finished his term as president of Threshold Foundation, a community of individuals united by their commitment to create a just, joyful and generative world.

Meck currently holds positions on the board of directors of the Pancreatic Cancer Action Network, Movement Advancement Project, God’s Love We Deliver and The Provincetown Commons. He received his BA from Princeton University and splits his time between New Orleans and Provincetown, Massachusetts.  

back to top


Stuart Rickerson

Rancho Santa Fe, CA

Stuart Rickerson, after 25 years experience as an executive and corporate legal officer, had his distinguished business career in the pharmaceutical and medical device industries cut short when he was diagnosed with pancreas cancer in January 2005. As a consequence, he was forced into retirement from the day-to-day management of complex international health care companies. He is recognized as a leader in board and corporate governance, performance-based executive compensation and using the legal process to achieve strategic business and competitive advantage. He has served on several publicly-traded NYSE and NASDAQ boards during his career.

His focus now is to increase research funding into identifying the causes, and improving the diagnosis, treatment and long-term care of patients with this disease. Although pancreas cancer is the fourth leading cause of cancer death in America, it receives far less research funding than far less deadly diseases.

Rickerson helped lead the business, financial and cultural transformation of ALARIS Medical Systems, the leading innovator in medication management instruments to reduce medication errors, based in San Diego and England. Earlier in his career, he helped lead the strategic re-focus of Cardiac Pacemakers, Inc. based in Minneapolis, which was renamed Guidant after it pioneered the development of the implantable defibrillator, a device that now saves several hundred thousand lives each year. He began his business career in the 1980s with global pharmaceutical giant, Eli Lilly & Company, based in Indianapolis. He also served on the Board of Directors of mini-conglomerate, Keene Corporation, based in New York, in the 1990s. He also consulted with more than two dozen Fortune 500 companies. His work has been featured in business publications, including Forbes, Business Week, and The Wall Street Journal.

Rickerson is also a co-founder of two endowment boards associated with Princeton University, where both he and his spouse, Nancy, graduated. They live in Rancho Santa Fe, California and New York City. He took his law degree from Georgetown. In 2007, Princeton established a multi-million dollar athletic fields endowment for the “Rickerson Family Field,” for the work he and his wife have done for their alma mater. Due to his 40 years of support, New Jersey’s state intercollegiate rugby championship is named “The Rickerson Cup.”

Rickerson also serves on the board of a “no strings attached” memorial scholarship for graduating seniors who demonstrate their exceptional character and ability to maintain a positive attitude while overcoming significant adversity at Ridge High School in Basking Ridge, NJ, from which he graduated.

back to top


Craig A. Rogerson

Philadelphia, PA

Craig Rogerson is Chairman, President and Chief Executive Officer at Hexion Inc. A father to three, Rogerson lost his first wife Carina to pancreatic cancer in 2009.

Rogerson joined Hexion in July 2017. Prior to joining Hexion, Rogerson served as Chairman, President and Chief Executive Officer of Chemtura Corporation, a position he held from December 2008 until April 21, 2017. Rogerson also served as President, Chief Executive Officer and Director of Hercules Incorporated from December 2003 until November 2008. Rogerson joined Hercules in 1979 and served in a number of management positions before leaving the company to serve as President and Chief Executive Officer of Wacker Silicones Corporation in 1997. In May 2000, Rogerson rejoined Hercules and was named President of its BetzDearborn Division in August 2000. Prior to being named CEO of Hercules in December 2003, Rogerson held a variety of senior management positions with the company, including president of the FiberVisions and Pinova Divisions, vice president of Global Procurement, and Chief Operating Officer.

Mr. Rogerson serves on the boards of directors of PPL, the Society of Chemical Industry, and the American Chemistry Council.

He holds a chemical engineering degree from Michigan State University, and serves on the advisory board of the Michigan State University Department of Chemical Engineering & Materials Science (MSU CHEMS).

back to top


Karen Young, CPA

New Jersey

Karen Young, CPA, joined the Pancreatic Cancer Action Network (PanCAN) Board of Directors in May 2018. Young brings 23 years of professional and strategic development expertise to the distinguished role.

Young became impassioned to assist in finding a cure for pancreatic cancer after losing both her father and her aunt to the disease.

Currently, Young works as PricewaterhouseCoopers’ (PwC) U.S. Pharmaceutical and Life Sciences Leader (PLS). In this role, she leads more than 3,000 professionals in delivering PwC’s advisory, tax and assurance services. She drives the strategic direction in client service, capabilities and thought leadership. Young has deep relationships within the marketplace and has a proven track record in delivering the highest service, leveraging the expertise within the geographies, industry and across all PwC’s lines of service.

Outside of the PwC office, Young has received several accolades, including NJBIZ’s Best 50 Women in Business Award and the Healthcare Businesswomen’s Association’s (HBA) Rising Star Award. Additionally, Young is active as a presenter and moderator at several life sciences forums, including CBI Accounting and Reporting Congress and BioNJ. She has authored multiple publications, articles and alerts on accounting and technical matters impacting the industry and broader industry topics, such as the future of healthcare.

Young is a graduate of Villanova University. She lives in New Jersey with her husband Bill and three children: Andrew, Brian and Mary.

back to top

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.